EXECUTIVE ENGAGEMENTS
POOL
20001
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
1802
Interactions with Platform & by Email
PARTICIPANTS
402
Unique # Participated
VALIDATIONS
82
Responses Validated*
COMPANIES
38
Responses Validated*
* Login for a full stack data experience
DATE
JAN 2022
TABLES
102
PAGES
171
EDITION
6
PRICE
USD 5450
CODE
MCP12539
*Engagement stats are ongoing and dynamic
RESEARCH MODULES
EXECUTIVES
HIGHLIGHTS & REPORT INDEX
What's New for 2022?
» Global competitiveness and key competitor percentage market shares
» Market presence across multiple geographies - Strong/Active/Niche/Trivial
» Online interactive peer-to-peer collaborative bespoke updates
» Access to our digital archives and MarketGlass Research Platform
» Complimentary updates for one year
Amid the COVID-19 crisis, the global market for Immunoprotein Diagnostic Testing estimated at US$19.9 Billion in the year 2020, is projected to reach a revised size of US$30 Billion by 2027, growing at a CAGR of 6% over the analysis period 2020-2027. Immunoglobulin diagnostic tests, one of the segments analyzed in the report, is projected to record a 7% CAGR and reach US$9.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the C-Reactive Protein (CRP) Diagnostic Test segment is readjusted to a revised 6.3% CAGR for the next 7-year period.
The Immunoprotein Diagnostic Testing market in the U.S. is estimated at US$5.9 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$5.3 Billion by the year 2027 trailing a CAGR of 5.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.7% and 4.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.9% CAGR.
In the global Free Light Chain Diagnostic Tests segment, USA, Canada, Japan, China and Europe will drive the 4.8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$2.7 Billion in the year 2020 will reach a projected size of US$3.8 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$3.4 Billion by the year 2027.
SELECT PLAYERS
Abbott Laboratories; Abcam PLC; Bio-Rad Laboratories, Inc.; Danaher Corporation; DiaSorin SpA; Enzo Biochem, Inc.; F. Hoffmann-La Roche AG; Ortho Clinical Diagnostics; Siemens AG; Thermo Fisher Scientific, Inc.
SEGMENTS
» Application (Infectious Disease Testing, Oncology Testing, Endocrine Testing, Autoimmune Disease Testing, Allergy Testing, Toxicology Testing) » Technology (Enzyme-Based Immunoassay, Immunoturbidity Assay, Radioimmunoassay, Chemiluminescence Assay, Other Technologies) » Test Type (Immunoglobulin diagnostic tests, C-Reactive Protein (CRP) Diagnostic Test, Free Light Chain Diagnostic Tests, Complement System Proteins Diagnostic Tests, Haptoglobin Diagnostic Tests, Prealbumin Diagnostic Tests)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Current & Future Analysis for Immunoprotein Diagnostic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Immunoprotein Diagnostic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Immunoprotein Diagnostic Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Immunoglobulin diagnostic tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Immunoglobulin diagnostic tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Immunoglobulin diagnostic tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for C-Reactive Protein (CRP) Diagnostic Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for C-Reactive Protein (CRP) Diagnostic Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for C-Reactive Protein (CRP) Diagnostic Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Free Light Chain Diagnostic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Free Light Chain Diagnostic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Free Light Chain Diagnostic Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Complement System Proteins Diagnostic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Complement System Proteins Diagnostic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Complement System Proteins Diagnostic Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Haptoglobin Diagnostic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Haptoglobin Diagnostic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Haptoglobin Diagnostic Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Prealbumin Diagnostic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Prealbumin Diagnostic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Prealbumin Diagnostic Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Enzyme-Based Immunoassay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Enzyme-Based Immunoassay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Enzyme-Based Immunoassay by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Immunoturbidity Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Immunoturbidity Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Immunoturbidity Assay by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Radioimmunoassay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Radioimmunoassay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Radioimmunoassay by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Chemiluminescence Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Chemiluminescence Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Chemiluminescence Assay by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Infectious Disease Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Infectious Disease Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Infectious Disease Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Oncology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Oncology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Oncology Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Endocrine Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Endocrine Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Endocrine Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Autoimmune Disease Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Autoimmune Disease Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Autoimmune Disease Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Allergy Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Allergy Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Allergy Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Toxicology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Toxicology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Toxicology Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| USA Current & Future Analysis for Immunoprotein Diagnostic Testing by Test Type - Immunoglobulin diagnostic tests, C-Reactive Protein (CRP) Diagnostic Test, Free Light Chain Diagnostic Tests, Complement System Proteins Diagnostic Tests, Haptoglobin Diagnostic Tests and Prealbumin Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Immunoprotein Diagnostic Testing by Test Type - Immunoglobulin diagnostic tests, C-Reactive Protein (CRP) Diagnostic Test, Free Light Chain Diagnostic Tests, Complement System Proteins Diagnostic Tests, Haptoglobin Diagnostic Tests and Prealbumin Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Immunoprotein Diagnostic Testing by Test Type - Percentage Breakdown of Value Sales for Immunoglobulin diagnostic tests, C-Reactive Protein (CRP) Diagnostic Test, Free Light Chain Diagnostic Tests, Complement System Proteins Diagnostic Tests, Haptoglobin Diagnostic Tests and Prealbumin Diagnostic Tests for the Years 2012, 2020 & 2027 |
| USA Current & Future Analysis for Immunoprotein Diagnostic Testing by Technology - Enzyme-Based Immunoassay, Immunoturbidity Assay, Radioimmunoassay, Chemiluminescence Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Immunoprotein Diagnostic Testing by Technology - Enzyme-Based Immunoassay, Immunoturbidity Assay, Radioimmunoassay, Chemiluminescence Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Immunoprotein Diagnostic Testing by Technology - Percentage Breakdown of Value Sales for Enzyme-Based Immunoassay, Immunoturbidity Assay, Radioimmunoassay, Chemiluminescence Assay and Other Technologies for the Years 2012, 2020 & 2027 |
| USA Current & Future Analysis for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Endocrine Testing, Autoimmune Disease Testing, Allergy Testing and Toxicology Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Endocrine Testing, Autoimmune Disease Testing, Allergy Testing and Toxicology Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Immunoprotein Diagnostic Testing by Application - Percentage Breakdown of Value Sales for Infectious Disease Testing, Oncology Testing, Endocrine Testing, Autoimmune Disease Testing, Allergy Testing and Toxicology Testing for the Years 2012, 2020 & 2027 |
| CANADA |
| Canada Current & Future Analysis for Immunoprotein Diagnostic Testing by Test Type - Immunoglobulin diagnostic tests, C-Reactive Protein (CRP) Diagnostic Test, Free Light Chain Diagnostic Tests, Complement System Proteins Diagnostic Tests, Haptoglobin Diagnostic Tests and Prealbumin Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Immunoprotein Diagnostic Testing by Test Type - Immunoglobulin diagnostic tests, C-Reactive Protein (CRP) Diagnostic Test, Free Light Chain Diagnostic Tests, Complement System Proteins Diagnostic Tests, Haptoglobin Diagnostic Tests and Prealbumin Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Immunoprotein Diagnostic Testing by Test Type - Percentage Breakdown of Value Sales for Immunoglobulin diagnostic tests, C-Reactive Protein (CRP) Diagnostic Test, Free Light Chain Diagnostic Tests, Complement System Proteins Diagnostic Tests, Haptoglobin Diagnostic Tests and Prealbumin Diagnostic Tests for the Years 2012, 2020 & 2027 |
| Canada Current & Future Analysis for Immunoprotein Diagnostic Testing by Technology - Enzyme-Based Immunoassay, Immunoturbidity Assay, Radioimmunoassay, Chemiluminescence Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Immunoprotein Diagnostic Testing by Technology - Enzyme-Based Immunoassay, Immunoturbidity Assay, Radioimmunoassay, Chemiluminescence Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Immunoprotein Diagnostic Testing by Technology - Percentage Breakdown of Value Sales for Enzyme-Based Immunoassay, Immunoturbidity Assay, Radioimmunoassay, Chemiluminescence Assay and Other Technologies for the Years 2012, 2020 & 2027 |
| Canada Current & Future Analysis for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Endocrine Testing, Autoimmune Disease Testing, Allergy Testing and Toxicology Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Endocrine Testing, Autoimmune Disease Testing, Allergy Testing and Toxicology Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Immunoprotein Diagnostic Testing by Application - Percentage Breakdown of Value Sales for Infectious Disease Testing, Oncology Testing, Endocrine Testing, Autoimmune Disease Testing, Allergy Testing and Toxicology Testing for the Years 2012, 2020 & 2027 |
| JAPAN |
| Japan Current & Future Analysis for Immunoprotein Diagnostic Testing by Test Type - Immunoglobulin diagnostic tests, C-Reactive Protein (CRP) Diagnostic Test, Free Light Chain Diagnostic Tests, Complement System Proteins Diagnostic Tests, Haptoglobin Diagnostic Tests and Prealbumin Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Immunoprotein Diagnostic Testing by Test Type - Immunoglobulin diagnostic tests, C-Reactive Protein (CRP) Diagnostic Test, Free Light Chain Diagnostic Tests, Complement System Proteins Diagnostic Tests, Haptoglobin Diagnostic Tests and Prealbumin Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Immunoprotein Diagnostic Testing by Test Type - Percentage Breakdown of Value Sales for Immunoglobulin diagnostic tests, C-Reactive Protein (CRP) Diagnostic Test, Free Light Chain Diagnostic Tests, Complement System Proteins Diagnostic Tests, Haptoglobin Diagnostic Tests and Prealbumin Diagnostic Tests for the Years 2012, 2020 & 2027 |
| Japan Current & Future Analysis for Immunoprotein Diagnostic Testing by Technology - Enzyme-Based Immunoassay, Immunoturbidity Assay, Radioimmunoassay, Chemiluminescence Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Immunoprotein Diagnostic Testing by Technology - Enzyme-Based Immunoassay, Immunoturbidity Assay, Radioimmunoassay, Chemiluminescence Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Immunoprotein Diagnostic Testing by Technology - Percentage Breakdown of Value Sales for Enzyme-Based Immunoassay, Immunoturbidity Assay, Radioimmunoassay, Chemiluminescence Assay and Other Technologies for the Years 2012, 2020 & 2027 |
| Japan Current & Future Analysis for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Endocrine Testing, Autoimmune Disease Testing, Allergy Testing and Toxicology Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Endocrine Testing, Autoimmune Disease Testing, Allergy Testing and Toxicology Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Immunoprotein Diagnostic Testing by Application - Percentage Breakdown of Value Sales for Infectious Disease Testing, Oncology Testing, Endocrine Testing, Autoimmune Disease Testing, Allergy Testing and Toxicology Testing for the Years 2012, 2020 & 2027 |
| CHINA |
| China Current & Future Analysis for Immunoprotein Diagnostic Testing by Test Type - Immunoglobulin diagnostic tests, C-Reactive Protein (CRP) Diagnostic Test, Free Light Chain Diagnostic Tests, Complement System Proteins Diagnostic Tests, Haptoglobin Diagnostic Tests and Prealbumin Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Immunoprotein Diagnostic Testing by Test Type - Immunoglobulin diagnostic tests, C-Reactive Protein (CRP) Diagnostic Test, Free Light Chain Diagnostic Tests, Complement System Proteins Diagnostic Tests, Haptoglobin Diagnostic Tests and Prealbumin Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Immunoprotein Diagnostic Testing by Test Type - Percentage Breakdown of Value Sales for Immunoglobulin diagnostic tests, C-Reactive Protein (CRP) Diagnostic Test, Free Light Chain Diagnostic Tests, Complement System Proteins Diagnostic Tests, Haptoglobin Diagnostic Tests and Prealbumin Diagnostic Tests for the Years 2012, 2020 & 2027 |
| China Current & Future Analysis for Immunoprotein Diagnostic Testing by Technology - Enzyme-Based Immunoassay, Immunoturbidity Assay, Radioimmunoassay, Chemiluminescence Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Immunoprotein Diagnostic Testing by Technology - Enzyme-Based Immunoassay, Immunoturbidity Assay, Radioimmunoassay, Chemiluminescence Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Immunoprotein Diagnostic Testing by Technology - Percentage Breakdown of Value Sales for Enzyme-Based Immunoassay, Immunoturbidity Assay, Radioimmunoassay, Chemiluminescence Assay and Other Technologies for the Years 2012, 2020 & 2027 |
| China Current & Future Analysis for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Endocrine Testing, Autoimmune Disease Testing, Allergy Testing and Toxicology Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Endocrine Testing, Autoimmune Disease Testing, Allergy Testing and Toxicology Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Immunoprotein Diagnostic Testing by Application - Percentage Breakdown of Value Sales for Infectious Disease Testing, Oncology Testing, Endocrine Testing, Autoimmune Disease Testing, Allergy Testing and Toxicology Testing for the Years 2012, 2020 & 2027 |
| EUROPE |
| Europe Current & Future Analysis for Immunoprotein Diagnostic Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Immunoprotein Diagnostic Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Immunoprotein Diagnostic Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Immunoprotein Diagnostic Testing by Test Type - Immunoglobulin diagnostic tests, C-Reactive Protein (CRP) Diagnostic Test, Free Light Chain Diagnostic Tests, Complement System Proteins Diagnostic Tests, Haptoglobin Diagnostic Tests and Prealbumin Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Immunoprotein Diagnostic Testing by Test Type - Immunoglobulin diagnostic tests, C-Reactive Protein (CRP) Diagnostic Test, Free Light Chain Diagnostic Tests, Complement System Proteins Diagnostic Tests, Haptoglobin Diagnostic Tests and Prealbumin Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Immunoprotein Diagnostic Testing by Test Type - Percentage Breakdown of Value Sales for Immunoglobulin diagnostic tests, C-Reactive Protein (CRP) Diagnostic Test, Free Light Chain Diagnostic Tests, Complement System Proteins Diagnostic Tests, Haptoglobin Diagnostic Tests and Prealbumin Diagnostic Tests for the Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Immunoprotein Diagnostic Testing by Technology - Enzyme-Based Immunoassay, Immunoturbidity Assay, Radioimmunoassay, Chemiluminescence Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Immunoprotein Diagnostic Testing by Technology - Enzyme-Based Immunoassay, Immunoturbidity Assay, Radioimmunoassay, Chemiluminescence Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Immunoprotein Diagnostic Testing by Technology - Percentage Breakdown of Value Sales for Enzyme-Based Immunoassay, Immunoturbidity Assay, Radioimmunoassay, Chemiluminescence Assay and Other Technologies for the Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Endocrine Testing, Autoimmune Disease Testing, Allergy Testing and Toxicology Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Endocrine Testing, Autoimmune Disease Testing, Allergy Testing and Toxicology Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Immunoprotein Diagnostic Testing by Application - Percentage Breakdown of Value Sales for Infectious Disease Testing, Oncology Testing, Endocrine Testing, Autoimmune Disease Testing, Allergy Testing and Toxicology Testing for the Years 2012, 2020 & 2027 |
| FRANCE |
| France Current & Future Analysis for Immunoprotein Diagnostic Testing by Test Type - Immunoglobulin diagnostic tests, C-Reactive Protein (CRP) Diagnostic Test, Free Light Chain Diagnostic Tests, Complement System Proteins Diagnostic Tests, Haptoglobin Diagnostic Tests and Prealbumin Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Immunoprotein Diagnostic Testing by Test Type - Immunoglobulin diagnostic tests, C-Reactive Protein (CRP) Diagnostic Test, Free Light Chain Diagnostic Tests, Complement System Proteins Diagnostic Tests, Haptoglobin Diagnostic Tests and Prealbumin Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Immunoprotein Diagnostic Testing by Test Type - Percentage Breakdown of Value Sales for Immunoglobulin diagnostic tests, C-Reactive Protein (CRP) Diagnostic Test, Free Light Chain Diagnostic Tests, Complement System Proteins Diagnostic Tests, Haptoglobin Diagnostic Tests and Prealbumin Diagnostic Tests for the Years 2012, 2020 & 2027 |
| France Current & Future Analysis for Immunoprotein Diagnostic Testing by Technology - Enzyme-Based Immunoassay, Immunoturbidity Assay, Radioimmunoassay, Chemiluminescence Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Immunoprotein Diagnostic Testing by Technology - Enzyme-Based Immunoassay, Immunoturbidity Assay, Radioimmunoassay, Chemiluminescence Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Immunoprotein Diagnostic Testing by Technology - Percentage Breakdown of Value Sales for Enzyme-Based Immunoassay, Immunoturbidity Assay, Radioimmunoassay, Chemiluminescence Assay and Other Technologies for the Years 2012, 2020 & 2027 |
| France Current & Future Analysis for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Endocrine Testing, Autoimmune Disease Testing, Allergy Testing and Toxicology Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Endocrine Testing, Autoimmune Disease Testing, Allergy Testing and Toxicology Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Immunoprotein Diagnostic Testing by Application - Percentage Breakdown of Value Sales for Infectious Disease Testing, Oncology Testing, Endocrine Testing, Autoimmune Disease Testing, Allergy Testing and Toxicology Testing for the Years 2012, 2020 & 2027 |
| GERMANY |
| Germany Current & Future Analysis for Immunoprotein Diagnostic Testing by Test Type - Immunoglobulin diagnostic tests, C-Reactive Protein (CRP) Diagnostic Test, Free Light Chain Diagnostic Tests, Complement System Proteins Diagnostic Tests, Haptoglobin Diagnostic Tests and Prealbumin Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Immunoprotein Diagnostic Testing by Test Type - Immunoglobulin diagnostic tests, C-Reactive Protein (CRP) Diagnostic Test, Free Light Chain Diagnostic Tests, Complement System Proteins Diagnostic Tests, Haptoglobin Diagnostic Tests and Prealbumin Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Immunoprotein Diagnostic Testing by Test Type - Percentage Breakdown of Value Sales for Immunoglobulin diagnostic tests, C-Reactive Protein (CRP) Diagnostic Test, Free Light Chain Diagnostic Tests, Complement System Proteins Diagnostic Tests, Haptoglobin Diagnostic Tests and Prealbumin Diagnostic Tests for the Years 2012, 2020 & 2027 |
| Germany Current & Future Analysis for Immunoprotein Diagnostic Testing by Technology - Enzyme-Based Immunoassay, Immunoturbidity Assay, Radioimmunoassay, Chemiluminescence Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Immunoprotein Diagnostic Testing by Technology - Enzyme-Based Immunoassay, Immunoturbidity Assay, Radioimmunoassay, Chemiluminescence Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Immunoprotein Diagnostic Testing by Technology - Percentage Breakdown of Value Sales for Enzyme-Based Immunoassay, Immunoturbidity Assay, Radioimmunoassay, Chemiluminescence Assay and Other Technologies for the Years 2012, 2020 & 2027 |
| Germany Current & Future Analysis for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Endocrine Testing, Autoimmune Disease Testing, Allergy Testing and Toxicology Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Endocrine Testing, Autoimmune Disease Testing, Allergy Testing and Toxicology Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Immunoprotein Diagnostic Testing by Application - Percentage Breakdown of Value Sales for Infectious Disease Testing, Oncology Testing, Endocrine Testing, Autoimmune Disease Testing, Allergy Testing and Toxicology Testing for the Years 2012, 2020 & 2027 |
| ITALY |
| Italy Current & Future Analysis for Immunoprotein Diagnostic Testing by Test Type - Immunoglobulin diagnostic tests, C-Reactive Protein (CRP) Diagnostic Test, Free Light Chain Diagnostic Tests, Complement System Proteins Diagnostic Tests, Haptoglobin Diagnostic Tests and Prealbumin Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Immunoprotein Diagnostic Testing by Test Type - Immunoglobulin diagnostic tests, C-Reactive Protein (CRP) Diagnostic Test, Free Light Chain Diagnostic Tests, Complement System Proteins Diagnostic Tests, Haptoglobin Diagnostic Tests and Prealbumin Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Immunoprotein Diagnostic Testing by Test Type - Percentage Breakdown of Value Sales for Immunoglobulin diagnostic tests, C-Reactive Protein (CRP) Diagnostic Test, Free Light Chain Diagnostic Tests, Complement System Proteins Diagnostic Tests, Haptoglobin Diagnostic Tests and Prealbumin Diagnostic Tests for the Years 2012, 2020 & 2027 |
| Italy Current & Future Analysis for Immunoprotein Diagnostic Testing by Technology - Enzyme-Based Immunoassay, Immunoturbidity Assay, Radioimmunoassay, Chemiluminescence Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Immunoprotein Diagnostic Testing by Technology - Enzyme-Based Immunoassay, Immunoturbidity Assay, Radioimmunoassay, Chemiluminescence Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Immunoprotein Diagnostic Testing by Technology - Percentage Breakdown of Value Sales for Enzyme-Based Immunoassay, Immunoturbidity Assay, Radioimmunoassay, Chemiluminescence Assay and Other Technologies for the Years 2012, 2020 & 2027 |
| Italy Current & Future Analysis for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Endocrine Testing, Autoimmune Disease Testing, Allergy Testing and Toxicology Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Endocrine Testing, Autoimmune Disease Testing, Allergy Testing and Toxicology Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Immunoprotein Diagnostic Testing by Application - Percentage Breakdown of Value Sales for Infectious Disease Testing, Oncology Testing, Endocrine Testing, Autoimmune Disease Testing, Allergy Testing and Toxicology Testing for the Years 2012, 2020 & 2027 |
| UNITED KINGDOM |
| UK Current & Future Analysis for Immunoprotein Diagnostic Testing by Test Type - Immunoglobulin diagnostic tests, C-Reactive Protein (CRP) Diagnostic Test, Free Light Chain Diagnostic Tests, Complement System Proteins Diagnostic Tests, Haptoglobin Diagnostic Tests and Prealbumin Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Immunoprotein Diagnostic Testing by Test Type - Immunoglobulin diagnostic tests, C-Reactive Protein (CRP) Diagnostic Test, Free Light Chain Diagnostic Tests, Complement System Proteins Diagnostic Tests, Haptoglobin Diagnostic Tests and Prealbumin Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Immunoprotein Diagnostic Testing by Test Type - Percentage Breakdown of Value Sales for Immunoglobulin diagnostic tests, C-Reactive Protein (CRP) Diagnostic Test, Free Light Chain Diagnostic Tests, Complement System Proteins Diagnostic Tests, Haptoglobin Diagnostic Tests and Prealbumin Diagnostic Tests for the Years 2012, 2020 & 2027 |
| UK Current & Future Analysis for Immunoprotein Diagnostic Testing by Technology - Enzyme-Based Immunoassay, Immunoturbidity Assay, Radioimmunoassay, Chemiluminescence Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Immunoprotein Diagnostic Testing by Technology - Enzyme-Based Immunoassay, Immunoturbidity Assay, Radioimmunoassay, Chemiluminescence Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Immunoprotein Diagnostic Testing by Technology - Percentage Breakdown of Value Sales for Enzyme-Based Immunoassay, Immunoturbidity Assay, Radioimmunoassay, Chemiluminescence Assay and Other Technologies for the Years 2012, 2020 & 2027 |
| UK Current & Future Analysis for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Endocrine Testing, Autoimmune Disease Testing, Allergy Testing and Toxicology Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Endocrine Testing, Autoimmune Disease Testing, Allergy Testing and Toxicology Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Immunoprotein Diagnostic Testing by Application - Percentage Breakdown of Value Sales for Infectious Disease Testing, Oncology Testing, Endocrine Testing, Autoimmune Disease Testing, Allergy Testing and Toxicology Testing for the Years 2012, 2020 & 2027 |
| REST OF EUROPE |
| Rest of Europe Current & Future Analysis for Immunoprotein Diagnostic Testing by Test Type - Immunoglobulin diagnostic tests, C-Reactive Protein (CRP) Diagnostic Test, Free Light Chain Diagnostic Tests, Complement System Proteins Diagnostic Tests, Haptoglobin Diagnostic Tests and Prealbumin Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Immunoprotein Diagnostic Testing by Test Type - Immunoglobulin diagnostic tests, C-Reactive Protein (CRP) Diagnostic Test, Free Light Chain Diagnostic Tests, Complement System Proteins Diagnostic Tests, Haptoglobin Diagnostic Tests and Prealbumin Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Immunoprotein Diagnostic Testing by Test Type - Percentage Breakdown of Value Sales for Immunoglobulin diagnostic tests, C-Reactive Protein (CRP) Diagnostic Test, Free Light Chain Diagnostic Tests, Complement System Proteins Diagnostic Tests, Haptoglobin Diagnostic Tests and Prealbumin Diagnostic Tests for the Years 2012, 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Immunoprotein Diagnostic Testing by Technology - Enzyme-Based Immunoassay, Immunoturbidity Assay, Radioimmunoassay, Chemiluminescence Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Immunoprotein Diagnostic Testing by Technology - Enzyme-Based Immunoassay, Immunoturbidity Assay, Radioimmunoassay, Chemiluminescence Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Immunoprotein Diagnostic Testing by Technology - Percentage Breakdown of Value Sales for Enzyme-Based Immunoassay, Immunoturbidity Assay, Radioimmunoassay, Chemiluminescence Assay and Other Technologies for the Years 2012, 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Endocrine Testing, Autoimmune Disease Testing, Allergy Testing and Toxicology Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Endocrine Testing, Autoimmune Disease Testing, Allergy Testing and Toxicology Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Immunoprotein Diagnostic Testing by Application - Percentage Breakdown of Value Sales for Infectious Disease Testing, Oncology Testing, Endocrine Testing, Autoimmune Disease Testing, Allergy Testing and Toxicology Testing for the Years 2012, 2020 & 2027 |
| ASIA-PACIFIC |
| Asia-Pacific Current & Future Analysis for Immunoprotein Diagnostic Testing by Test Type - Immunoglobulin diagnostic tests, C-Reactive Protein (CRP) Diagnostic Test, Free Light Chain Diagnostic Tests, Complement System Proteins Diagnostic Tests, Haptoglobin Diagnostic Tests and Prealbumin Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Immunoprotein Diagnostic Testing by Test Type - Immunoglobulin diagnostic tests, C-Reactive Protein (CRP) Diagnostic Test, Free Light Chain Diagnostic Tests, Complement System Proteins Diagnostic Tests, Haptoglobin Diagnostic Tests and Prealbumin Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Immunoprotein Diagnostic Testing by Test Type - Percentage Breakdown of Value Sales for Immunoglobulin diagnostic tests, C-Reactive Protein (CRP) Diagnostic Test, Free Light Chain Diagnostic Tests, Complement System Proteins Diagnostic Tests, Haptoglobin Diagnostic Tests and Prealbumin Diagnostic Tests for the Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Immunoprotein Diagnostic Testing by Technology - Enzyme-Based Immunoassay, Immunoturbidity Assay, Radioimmunoassay, Chemiluminescence Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Immunoprotein Diagnostic Testing by Technology - Enzyme-Based Immunoassay, Immunoturbidity Assay, Radioimmunoassay, Chemiluminescence Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Immunoprotein Diagnostic Testing by Technology - Percentage Breakdown of Value Sales for Enzyme-Based Immunoassay, Immunoturbidity Assay, Radioimmunoassay, Chemiluminescence Assay and Other Technologies for the Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Endocrine Testing, Autoimmune Disease Testing, Allergy Testing and Toxicology Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Endocrine Testing, Autoimmune Disease Testing, Allergy Testing and Toxicology Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Immunoprotein Diagnostic Testing by Application - Percentage Breakdown of Value Sales for Infectious Disease Testing, Oncology Testing, Endocrine Testing, Autoimmune Disease Testing, Allergy Testing and Toxicology Testing for the Years 2012, 2020 & 2027 |
| REST OF WORLD |
| Rest of World Current & Future Analysis for Immunoprotein Diagnostic Testing by Test Type - Immunoglobulin diagnostic tests, C-Reactive Protein (CRP) Diagnostic Test, Free Light Chain Diagnostic Tests, Complement System Proteins Diagnostic Tests, Haptoglobin Diagnostic Tests and Prealbumin Diagnostic Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Immunoprotein Diagnostic Testing by Test Type - Immunoglobulin diagnostic tests, C-Reactive Protein (CRP) Diagnostic Test, Free Light Chain Diagnostic Tests, Complement System Proteins Diagnostic Tests, Haptoglobin Diagnostic Tests and Prealbumin Diagnostic Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Immunoprotein Diagnostic Testing by Test Type - Percentage Breakdown of Value Sales for Immunoglobulin diagnostic tests, C-Reactive Protein (CRP) Diagnostic Test, Free Light Chain Diagnostic Tests, Complement System Proteins Diagnostic Tests, Haptoglobin Diagnostic Tests and Prealbumin Diagnostic Tests for the Years 2012, 2020 & 2027 |
| Rest of World Current & Future Analysis for Immunoprotein Diagnostic Testing by Technology - Enzyme-Based Immunoassay, Immunoturbidity Assay, Radioimmunoassay, Chemiluminescence Assay and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Immunoprotein Diagnostic Testing by Technology - Enzyme-Based Immunoassay, Immunoturbidity Assay, Radioimmunoassay, Chemiluminescence Assay and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Immunoprotein Diagnostic Testing by Technology - Percentage Breakdown of Value Sales for Enzyme-Based Immunoassay, Immunoturbidity Assay, Radioimmunoassay, Chemiluminescence Assay and Other Technologies for the Years 2012, 2020 & 2027 |
| Rest of World Current & Future Analysis for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Endocrine Testing, Autoimmune Disease Testing, Allergy Testing and Toxicology Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Immunoprotein Diagnostic Testing by Application - Infectious Disease Testing, Oncology Testing, Endocrine Testing, Autoimmune Disease Testing, Allergy Testing and Toxicology Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Immunoprotein Diagnostic Testing by Application - Percentage Breakdown of Value Sales for Infectious Disease Testing, Oncology Testing, Endocrine Testing, Autoimmune Disease Testing, Allergy Testing and Toxicology Testing for the Years 2012, 2020 & 2027 |
| IV. COMPETITION |
| Total Companies Profiled: 38 |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com